Cardiologist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Chiropractor providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Dentist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Dermatologist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Family Physician providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
OB-GYN providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Ophthalmologist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Orthopedic Surgeon providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Pediatrician providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Physical Therapist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Podiatrist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Psychiatrist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Dr. Daniel Richard Reed specializes in radiation oncology, with a focus on breast and prostate cancers.
Dr. Reed co-founded Arizona Center for Cancer Care in 2008 with Drs. Devinder Singh, Christopher Biggs and Terry Lee. He received his Bachelor of Science in Chemistry and Biology from Western Kentucky University. He attended medical school at West Virginia School of Osteopathic Medicine, completed his internship at Doctors Hospital Ohio University and his residency at the University of Washington Medical Center, where he would eventually serve as Chief Resident and in 2002 earned the National Research Award in radiation oncology for his work in breast cancer treatment. He also served as the Seattle Prostate Institute/American Brachytherapy Society Prostate fellowship coordinator for several years.
In 2007, he authored the National Treatment Guidelines of the American College of Radiology for Prostate Cancer Radiation Therapy and the book chapter on Skull-based tumors in The Textbook of Radiation Oncology (2nd edition). He has also served as a scientific reviewer for the International Journal of Radiation Oncology and national representative of the American Brachytherapy Society.
Dr. Reed is certified by the American Board of Radiology and is a Diplomat of the American Society of Therapeutic Radiation Oncology. He is a current or past member of the American Brachytherapy Society, American Radium Society, American Radiology Resident Association, American Society of Clinical Oncology, American Medical Association and American Osteopathic Association, among others.
Dr. Reed is a multi-year “Top Doc” honoree by Phoenix Magazine and has over 70 combined 5-star reviews from happy patients.
"All the Staff are knowledgeable , understanding and cooperative accommodating to all of our needs." -Mike
"Dr. Reed and all of his staff were exceptionally professional and very friendly and helpful. Dr. Reed made sure I was receiving the best care for my issue and my final tests after treatment showed a great improvement. I highly recommend this Doctor and this facility." -Richard
Dr. Jason Samuelian is a Board-certified Radiation Oncologist, with expertise in novel radiation techniques including Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGRT), Stereotactic Radiosurgery (SRS), and Stereotactic Ablative Radiotherapy (SABR). He has a particular interest in using new and advanced treatment techniques to minimize side effects. He derives great satisfaction from spending time with his patients and developing relationships with them that last long beyond their cancer care.
Dr. Samuelian joined Arizona Center for Cancer Care in 2015. He earned his Bachelor of Science degree in Exercise Physiology from Brigham Young University, where he graduated cum laude. He earned his medical doctorate at Midwestern University in Glendale, where he was awarded the MICA Scholastic Award in 2008, and graduated with Honors in 2010. He completed an internal medicine internship at Banner Good Samaritan Medical Center, followed by residency training at the Baylor College of Medicine, where he also served as chief resident. In addition, Dr. Samuelian has completed two brachytherapy fellowships — at the MD Anderson Cancer Center and the Seattle Prostate Institute.
Dr. Samuelian is a member of the American Society of Therapeutic Radiation Oncology, American Brachytherapy Society, American College of Radiology, American College of Radiation Oncology, and the American Society of Clinical Oncology. He has been invited to serve on the ASCO Professional Development Committee. He currently serves as Chairman of the Cancer Committee at Banner Boswell Medical Center in Sun City, a program accredited by the Commission on Cancer (CoC).
Dr. Samuelian actively participates in cooperative group clinical trials. His research has been published in peer-reviewed medical journals, and he has presented at national meetings on SABR for COPD patients with early-stage lung cancer, IMRT for the treatment of rectal cancer, and prostate cancer brachytherapy, among others.
"Dr. Samuelian has always been very honest and truthful in presenting us with our options I trust his opinion 100 present and would highly recommend him to anyone seeking his treatment." -Rick
"I have been very impressed with Dr. Jason Samuelian. He seems extremely knowledgeable. I have had several doctors that had horrible bedside manner. Dr. Samuelian has an incredible bedside manner. It was so obvious that he was really concerned with my welfare. I would also like to do a shout out to his support team. They were incredible, and kind. I can't say enough about the entire experience. I'd give him six stars if I could." -Peter
Kamlesh Kumar Sankhala MD (also known as Dr. Kumar by his patients and colleagues) is a Medical Oncologist at Cedars-Sinai Medical Center in Los Angeles, California, and Director of Precision NextGen Oncology and Research Center, an independent center focused on treatment of complex, rare cancer and Sarcomas, as well as, clinical research in Oncology for expedited drug development and clinical research. Precision NextGen Oncology and Research Center focuses on care for patients with Advanced Cancers who are refractory to conventional treatments. We provide care to these patients with multi- institutional coordinated care and access to novel and next generation therapies with or without clinical trials.
Dr. Sankhala specializes in clinical research and has pioneered a niche in treatments for patients with advanced and complex malignancies refractory to conventional treatments, along with rare cancer such as sarcomas.
Dr. Sankhala received his medical degree at the University of Rajasthan, India and undertook his internal medicine residency and fellowship training in oncology at the University of Texas Health Science Center. He had two years of additional fellowship in Oncology Drug Development at the University of Texas’s Institute for Drug Development. He was a clinical faculty at the University of Texas’s Health Science Center, and Clinical Investigator at the Institute for Drug Development (IDD). He also served as team leader for the University’s Sarcoma Program. Dr. Sankhala has served as the Co-Director, Sarcoma Medical Oncology and the Director of Clinical Research and Experimental Therapeutics Cedars-Sinai Medical Center’s THO.
Besides his Medical Oncology practice in advanced refractory cancers, Dr. Sankhala’s research focuses on translational research of novel anti-cancer agents and on studying the pre-clinical and clinical aspects of these agents. With an esteemed background in novel drug research and phase-1 clinical trials, Dr. Sankhala has evolved into a physician devoted to the translational research of novel anti-cancer agents by applying himself to the study and evaluation of pre-clinical and clinical implications of new agents in patients with advanced cancers. He has developed a clinical proficiency in using novel anticancer drugs for patients with advanced malignancies and has optimized existing chemotherapeutic agents by reducing toxicities and increasing efficacy, thereby yielding better responses to anti-cancer therapies. Dr. Sankhala's extensive clinical research background includes serving as the principal investigator and sub-investigator in more than 250 Phase-1 and other Oncology clinical trials.
Dr. Sankhala has served on advisory boards for many pharmaceutical companies to design, implicate, and conduct research on many novel oncology therapeutic molecules and has also helped several other companies to optimize and find the marketplace for novel therapies. He has also served as a member of Protocol Review and Management Committee (PRMC) and institutional review board (IRB) at Samuel Oschin Cancer Center at Cedars-Sinai Cancer Institute in Los Angeles.
Dr. Sankhala has been a reviewer of reputed journals in the field of Oncology such as the British Journal of Cancer, Cancer Chemotherapy & Pharmacology, Journal of Medical Case Report, Onkologie, and Bone Marrow Transplantation. He is an editorial board member for the Journal of Cancer Science, and Therapy and Chemotherapy.
Dr. Sankhala’s has authored and co-authored 71 numerous articles, and abstracts in journals including Journal of Clinical Oncology, Clinical Cancer Research, Oncology immunology, Investigational New Drugs, Cancer Journal, Expert Review in Hematology, Cancer chemotherapy and Pharmacology, JAMA Oncology, Clinical Breast Cancer, Cancer Chemotherapy Pharmacology, Molecular Cancer Therapeutics, Leukemia Lymphoma, Current Drug Target, Expert Opinion in Investigational Drugs, Future Oncology, Target Oncology, Expert opinion in Drug Metabolism and Toxicology, and Clinical Advancement in Hematology Oncology.
He is the recipient of the American Society of Clinical Oncology Foundation’s Merit Award and the AACR- NCI scholarship for Molecular Biology in Clinical Oncology.
He has presented in many major national and international meetings including the American Society of Clinical Oncology (ASCO), Connective Tissue Oncology Society (CTOS), Japan’s Sarcoma Society, and many others.
Beside Cedars-Sinai Medical Center, Dr. Sankhala has affiliations with various esteemed health facilities across Los Angeles, including Univversity of California at Los Angeles, University of Southern California and Providence Saint John's Health Center.
Dr. Sankhala’s academic interests extend to progressive fields including Healthcare Utilization Management, Managed Care, Consumer-Directed Healthcare, Healthcare Economics, and Medical Oncology Trend Management.
Nimi Tuamokumo, MD MPH graduated cum laude from Princeton University with a Bachelor of Arts degree in the Psychology. She received her M.D. from Yale University School of Medicine in New Haven, CT and her MPH degree from Harvard School of Public Health.
Dr. Tuamokumo completed an internship in the Department of Medicine at Mount Auburn Hospital in Cambridge, MA and a residency in Radiation Oncology at the Harvard Radiation Oncology Program. Dr. Tuamokumo specializes in Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGRT), Stereotactic Body Radiation Therapy (SBRT).
She is experienced in treating all types of malignancies. Dr. Tuamokumo has been with GHRO since completion of her residency in 2008. She has received many awards, including the National Institutes of Health Careers in Medicine Fellowship, American Cancer Society Outstanding Thesis Award, New England Cancer Society’s Daland Resident Award, NIH Cancer Education Grant, Etta S. Chidsey Award in Cancer Research.
Dr. Tuamokumo has published articles and given presentations on a range of topics including breast cancer, prostate cancer, pediatric cancer, and gastric cancer. She is a member of the Texas Medical Association, the American Society of Clinical Oncology, and the American Society for Therapeutic Radiology and Oncology.
Dr. Theodore K. Yang received his undergraduate degree at The University of Texas at Austin in physics and went on to work as a medical physicist before attending medical school. He received his medical degree and completed residency training in radiation oncology at The University of Texas Medical Branch at Galveston (UTMB).
He then joined the UTMB faculty specializing in head and neck therapy and brachytherapy. Board certified in therapeutic radiology, Dr. Yang has practiced radiation oncology Houston since 1984.
Dr. Yang is a member of professional medical societies, including the Harris County Medical Society, Texas Medical Association, American Medical Association, ASTRO (American Society for Therapeutic Radiology and Oncology) and CADAH (Chinese American Doctors Association of Houston).
Dr. Theodore K. Yang received his undergraduate degree at The University of Texas at Austin in physics and went on to work as a medical physicist before attending medical school. He received his medical degree and completed residency training in radiation oncology at The University of Texas Medical Branch at Galveston (UTMB).
He then joined the UTMB faculty specializing in head and neck therapy and brachytherapy. Board certified in therapeutic radiology, Dr. Yang has practiced radiation oncology Houston since 1984.
Dr. Yang is a member of professional medical societies, including the Harris County Medical Society, Texas Medical Association, American Medical Association, ASTRO (American Society for Therapeutic Radiology and Oncology) and CADAH (Chinese American Doctors Association of Houston).
Nimi Tuamokumo, MD MPH graduated cum laude from Princeton University with a Bachelor of Arts degree in the Psychology. She received her M.D. from Yale University School of Medicine in New Haven, CT and her MPH degree from Harvard School of Public Health.
Dr. Tuamokumo completed an internship in the Department of Medicine at Mount Auburn Hospital in Cambridge, MA and a residency in Radiation Oncology at the Harvard Radiation Oncology Program. Dr. Tuamokumo specializes in Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGRT), Stereotactic Body Radiation Therapy (SBRT).
She is experienced in treating all types of malignancies. Dr. Tuamokumo has been with GHRO since completion of her residency in 2008. She has received many awards, including the National Institutes of Health Careers in Medicine Fellowship, American Cancer Society Outstanding Thesis Award, New England Cancer Society’s Daland Resident Award, NIH Cancer Education Grant, Etta S. Chidsey Award in Cancer Research.
Dr. Tuamokumo has published articles and given presentations on a range of topics including breast cancer, prostate cancer, pediatric cancer, and gastric cancer. She is a member of the Texas Medical Association, the American Society of Clinical Oncology, and the American Society for Therapeutic Radiology and Oncology.
Nimi Tuamokumo, MD MPH graduated cum laude from Princeton University with a Bachelor of Arts degree in the Psychology. She received her M.D. from Yale University School of Medicine in New Haven, CT and her MPH degree from Harvard School of Public Health.
Dr. Tuamokumo completed an internship in the Department of Medicine at Mount Auburn Hospital in Cambridge, MA and a residency in Radiation Oncology at the Harvard Radiation Oncology Program. Dr. Tuamokumo specializes in Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGRT), Stereotactic Body Radiation Therapy (SBRT).
She is experienced in treating all types of malignancies. Dr. Tuamokumo has been with GHRO since completion of her residency in 2008. She has received many awards, including the National Institutes of Health Careers in Medicine Fellowship, American Cancer Society Outstanding Thesis Award, New England Cancer Society’s Daland Resident Award, NIH Cancer Education Grant, Etta S. Chidsey Award in Cancer Research.
Dr. Tuamokumo has published articles and given presentations on a range of topics including breast cancer, prostate cancer, pediatric cancer, and gastric cancer. She is a member of the Texas Medical Association, the American Society of Clinical Oncology, and the American Society for Therapeutic Radiology and Oncology.
Dr. Theodore K. Yang received his undergraduate degree at The University of Texas at Austin in physics and went on to work as a medical physicist before attending medical school. He received his medical degree and completed residency training in radiation oncology at The University of Texas Medical Branch at Galveston (UTMB).
He then joined the UTMB faculty specializing in head and neck therapy and brachytherapy. Board certified in therapeutic radiology, Dr. Yang has practiced radiation oncology Houston since 1984.
Dr. Yang is a member of professional medical societies, including the Harris County Medical Society, Texas Medical Association, American Medical Association, ASTRO (American Society for Therapeutic Radiology and Oncology) and CADAH (Chinese American Doctors Association of Houston).
Dr. Benjamin Ball grew up in a smaller town within the New York Tri-State area. As a young adult, he moved to Charlottesville, Virginia where he completed a double major in chemistry and biology at the University of Virginia, graduating with high honors. He remained at UVA for medical school, where his pre-clerkship GPA was top five in his class. He then completed his neurosurgical residency at the University of California, Irvine, where he spent a year completing an enfolded skull-base surgery fellowship. His surgical interests include tumors, spine, and trauma. In his free time, he enjoys watching movies, reading science fiction books, attending local comedy shows, and watching UVA Men’s Basketball dominate.
Dr. Singavi’s clinical interests include solid tumors and hematologic disorders (both malignant and non-malignant – thrombotic/bleeding disorders/etc.). His special interests include Neuro-oncology, Breast Oncology, and Genitourinary.
When not working, Dr. Singavi enjoys spending time with his family, traveling, and watching sports.
"My father has been a patient of Dr Singavi for 3 years. Dr Singavi is an absolute gem! He is compassionate and very knowledgeable. He takes his time to listen to patient concerns and help the patient/family understand the treatment plan. I can’t say enough how grateful I am my father is in his care. It’s so rare to find a doctor that is both skilled in his field and has top notch bed side manor. Dr Singavi is both!!" -Laura
"Dr. Singavi is the most amazing Dr. He is kind, compassionate, and takes all the time in the world to make sure you understand your condition, and your treatment plan. His entire office staff is also very compassionate and carring. If you have to see an Oncologist, and let's face it, nobody wants to, Dr. Singavi and his staff are the people you want to be with during your care." -Sandy
Karlee grew up in a small town in Southern Wisconsin and went on to attend St. Cloud State University in Minnesota, where she played NCAA college soccer. After earning a degree in biomedical science with magna cum laude honors, she pursued her passion for medicine by obtaining a Physician Assistant degree from Northern Arizona University. During her time at Northern Arizona University she was an Arizona Area Health Education Center Scholar, engaging in a comprehensive two year interprofessional program that focused on preparing healthcare professionals for practice in underserved communities. This experience combined hands-on clinical training with community based learning, fostering a deep understanding of diverse patient needs.
Outside of work she enjoys reading, running, yoga, and spending quality time with family. Her commitment to ongoing learning and staying current with the latest medical advancements ensures that she is always equipped to deliver high quality care to her patients.
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Craig Hullett, MD, PhD, is a board-certified radiation oncologist with extensive experience in the treatment of a wide range of malignancies. He began his academic career in Communication, earning a Bachelor of Arts from Augustana College in Rock Island, Illinois, followed by a Master of Arts from Wake Forest University and a Doctor of Philosophy from Michigan State University. He later served as a tenured Associate Professor of Communication at the University of Arizona.
Inspired by his volunteer work at a local hospice, Dr. Hullett transitioned to medicine and earned his Doctor of Medicine degree from the University of Arizona. During medical school, he was inducted into the Gold Humanism Honor Society and Alpha Omega Alpha, recognizing his commitment to compassionate, patient-centered care and academic excellence. He completed his internship and residency training in Radiation Oncology at the University of Wisconsin.
Dr. Hullett has been practicing in Arizona since 2022 and is pleased to have returned to the state with his family. Outside of his clinical practice, he enjoys spending time with his family, exercising, and traveling.
Dr. Dhillon is fellowship trained in Hematology and Medical Oncology. His clinical interests include a broad spectrum of disorders including solid tumors, hematologic malignancies, and benign hematologic disorders. His special interests include pancreatic cancer, breast cancer, myeloma, lymphoma, gastrointestinal malignancies, prostate cancer, and lung cancer. Dr. Dhillon also specializes in treatment of blood disorders.
Dr. Dhillon has participated in a number of research projects. He has presented his work at national meetings, and published in journals, including the New England Journal of Medicine.
He is an advocate of collaborative and patient-centered cancer care that delivers effective treatment while maintaining quality of life.
Dr. Dhillon enjoys golf, writing, activities related to personal fitness, hiking, traveling, and spending time with friends and family.
"I am a snowbird and had no idea who would be a good oncologist during the winter to treat me. When I read about him online, he was one of my top choices and I’m glad I picked him. He has been the perfect fit for me. Not only does he have a friendly personality, but he is very thorough and caring. He is also very efficient as well. If he says he will do something, you can depend on him to do it. I feel that I am in very good hands here. Thank you Dr. Dhillon! I will tell my Idaho friends about you." -Marilyn
"When I come to Dr Dhillon’s office I can honestly say that I have never felt so loved and cared for in any physician’s office. The staff there is excellent beginning with checking in. They are so polite and helpful. All of the nurses take a personal interest to aid me to get my most outstanding care. The encouragement I get from all of them is phenomenal! I may come in down and dejected but by the time I leave I feel like there is a bright light at the end of the tunnel!!" [click the link below to read the rest] -Linda
Craig Hullett, MD, PhD, is a board-certified radiation oncologist with extensive experience in the treatment of a wide range of malignancies. He began his academic career in Communication, earning a Bachelor of Arts from Augustana College in Rock Island, Illinois, followed by a Master of Arts from Wake Forest University and a Doctor of Philosophy from Michigan State University. He later served as a tenured Associate Professor of Communication at the University of Arizona.
Inspired by his volunteer work at a local hospice, Dr. Hullett transitioned to medicine and earned his Doctor of Medicine degree from the University of Arizona. During medical school, he was inducted into the Gold Humanism Honor Society and Alpha Omega Alpha, recognizing his commitment to compassionate, patient-centered care and academic excellence. He completed his internship and residency training in Radiation Oncology at the University of Wisconsin.
Dr. Hullett has been practicing in Arizona since 2022 and is pleased to have returned to the state with his family. Outside of his clinical practice, he enjoys spending time with his family, exercising, and traveling.
Specializing in treating benign and malignant breast disease, Dr. Cox has a special interest in breast conservation and minimally-invasive techniques. With this emphasis, she helps each patient choose the best surgical and oncologic results while preserving as much normal breast tissue as possible.
After completing undergraduate and graduate degrees at California State University, Dr. Cox graduated from Flinders University of South Australia. She completed her general surgery training at Pennsylvania State University's Milton S. Hershey Medical Center and a Breast Surgical Oncology fellowship at The Cancer Institute of New Jersey/UMDNJ-Robert Wood Johnson Hospital.
In her spare time, Dr. Cox enjoys Bikram yoga and hiking in the Arizona foothills with her two shiba inus. She travels and, in particular, enjoys the beautiful cultures and histories of the Asian continent.
"Dr. Cox is a fantastic Dr./surgeon. I went to her after receiving positive cancer biopsy results. That in and of itself is super scary, let alone not knowing what was going to happen next. This wonderful, warm Dr. sat next to me and explained everything so I could understand it. Dr Cox took her time with me, she drew pictures to show me everything that was going on and what she was going to do. Dr. Cox tells you how it is in the most compassionate way. I felt very cared for. I had a lumpectomy with sentinel node biopsy. She did a beautiful job surgically. The follow up phone calls were made in a timely manner. Her staff is wonderful as well. I highly recommend Dr. Cox and going forward should I do mastectomy she will be my surgeon hands down!" -Deborah
"I took my wife to our 1st consultation. The experience was very informative. Dr Cox spent the time to go through all our options. She was so personable and kind I left her office with my wife feeling we have made the best choice in the valley. Looking forward to our journey with her on our team. I highly recommend her." -Pete
/assets/images/provider/photos/2293804.jpg)
/assets/images/provider/photos/2293804.jpg)
/assets/images/provider/photos/2227888.jpg)
/assets/images/provider/photos/2227888.jpg)
/assets/images/provider/photos/2227884.png)
/assets/images/provider/photos/2227884.png)
